NASDAQ:MDXG
Mimedx Group, Inc.
Mimedx Group, Inc.'s revenue grew 20.0% in fiscal 2025 to $418.6M while operating margin fell to 15.3%.Summary generated from Mimedx Group, Inc.'s SEC filings. Latest annual report filed Feb 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$418.6M
Revenue growth+20.0%
Revenue, 5-yr CAGR+11.0%
Gross margin82.6%
Operating margin15.3%
Net margin11.6%
ROIC43.3%
Return on equity21.6%
Debt / equity0.07
Free cash flown/a
FCF marginn/a
Share count change+0.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 242 | 268 | 321 | 349 | 419 |
| Operating income | −7 | −15 | 37 | 59 | 64 |
| Net income | −10 | −30 | 58 | 42 | 49 |
| Free cash flow | −5 | −19 | 25 | n/a | n/a |
Recent filings
- 8-K/AAmended entry into a material agreement
Aug 11, 2026 - 8-KResults of operations and financial condition
Jul 29, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 29, 2026 - 8-KEntry into a material agreement
Jul 29, 2026 - 4Insider transaction report
Jul 7, 2026 - 4Insider transaction report
Jun 25, 2026 - 8-KAmendment to articles or bylaws
Jun 16, 2026 - DEF 14AProxy statement
Apr 29, 2026